Scientific deep-dive

How Many Daily Steps Help Weight Loss? The Program Data

Randomized weight-loss programs average about 8,200 to 8,500 steps a day, but no trial has proved a target causes the loss. What the program data show on steps, per-1,000-step effects, maintenance and how little of it was measured on GLP-1 drugs.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
8 min read·13 citations

In randomized weight-loss programs, participants averaged about 8,450 steps a day by the end of the weight-loss phase and held about 8,240 through maintenance, while keeping off 3.28% of their starting weight[1]. In a separate trial, those who lost at least 10% averaged 9,822 steps a day at 18 months[2]. So program averages sit around 8,200 to 8,500 steps, and the group that lost the most in one trial reached about 9,800, but no trial has assigned people to those counts and proved that the number causes the loss. The authors of the 8,500 figure call it “hypothesis-generating rather than prescriptive”[1].

Where the 8,500 figure comes from

The most direct source is a 2026 meta-analysis of randomized trials comparing nutrition-based lifestyle programs with usual care. Eighteen trials entered the review and 14 were pooled, covering 3,758 participants with a mean age of about 53[1]. Both arms started near 7,200 steps a day (7,280 versus 7,180)[1].

Saadeddine 2026: pooled steps and percent weight lost, lifestyle program versus usual care. Weight-loss phase averaged 7.88 months; maintenance phase averaged 10.27 months.
TimepointProgram steps/dayControl steps/dayBetween-group step differenceProgram weight lossControl weight lossBetween-group weight difference
End of weight-loss phase8,4547,4861,090 (95% CI 225.5 to 1,954.5)4.39%1.25%3.14 points
End of maintenance phase8,2416,7571,211 (95% CI 344.7 to 2,077.8)3.28%0.99%2.29 points

Read that table for what the programs achieved. The primary estimate of the gain over usual care was about 1,100 to 1,200 extra steps a day[1], well short of a jump to 10,000. The pooled control average was about 6,750 by the maintenance phase, not a significant change from baseline, while program participants stayed above 8,200[1].

The link to weight is thinner than the headline. Within the program arms, an exploratory meta-regression tied steps at the end of each phase to weight loss at maintenance (β 1.33 and 1.10)[1]. These programs combined diet with other behavior change, so the between-group weight difference cannot be credited to walking alone. Heterogeneity was very high, with I² above 93% for the pooled step estimates, and the step difference was sensitive to an assumption about variance, falling to roughly 300 to 550 steps and losing significance under two other plausible values. The between-group weight difference also lost significance under some assumptions[1]. The authors also suggest that loss during the active phase owes more to calorie restriction than to daily steps, with steps mattering more for maintenance[1].

Where the 10,000 figure comes from

Secondary analysis of the Step-Up trial sorted 260 adults (mean BMI 32.8) by how much weight they had lost after an 18-month program of calorie restriction and prescribed activity[2]. Steps at 18 months rose with weight loss: 7,801 in those who gained, 7,802 in those who lost under 5%, 8,612 in those who lost 5% to under 10%, and 9,822 in those who lost at least 10%[2]. Steps taken in moderate-to-vigorous bouts of 10 minutes or more separated the groups even more clearly, at 3,482 in the top group versus 1,075 in the group that gained[2].

The grouping was done after the fact, so the arrow can run both ways: walking may help people lose weight, and people who are losing weight may find it easier to walk. Evidence testing 10,000 directly is scarce. A small 8-week study of 30 women with obesity on medical nutrition therapy compared 10,000 steps a day, 3 to 5 days a week, with 3,000 steps in a single 30-minute session. Body weight and fat fell in both groups, lean mass did not change, and metabolic markers showed no significant between-group differences[7].

What an extra 1,000 steps is worth

The clearest individual-level estimate here comes from the POUNDS Lost diet trial, where pedometers tracked participants assigned to four diets. Each 1,000 steps a day added was associated with an extra 0.48 kg lost from baseline to 6 months (382 participants), and 0.63 kg from baseline to 24 months (256 participants)[3]. Those with the largest activity increases held their loss from 6 to 24 months while those with smaller increases regained[3]. This is an association within a diet trial; steps were not the randomized variable.

When trials randomize the tracking tool itself, effects are modest. Pedometers and wearables added 0.65 kg and 1.08 kg of loss over control in two meta-analyses[4][5]. A small-change approach, using goals such as 1,000 more steps a day, did not produce weight loss, though it limited gain (−0.7 kg at program end), and only 2 of its 21 trials had a low risk of bias[6].

Randomized evidence on step tools and small-step goals. Differences are versus control.
SourceTrials and peoplePopulationWeight difference
Cai 2016, pedometers11 RCTs, 1,258Type 2 diabetes with overweight or obesity−0.65 kg (95% CI −1.12 to −0.17)
Wong 2022, wearables30 trials, 5,391Adults 18 to 64 with overweight or obesity−1.08 kg (95% CI −1.88 to −0.28)
Graham 2022, small changes21 trialsWeight-gain prevention trials in adults−0.7 kg at program end (95% CI −1.0 to −0.4); not effective for weight loss

The pedometer analysis adds a useful detail: dietary counseling seemed to be a key predictor of results, while setting a step goal had no significant influence[4]. That tension with the 8,500 headline is worth keeping in view. A number alone did little in those trials.

Steps or minutes of harder activity?

The data do not make steps the only metric that counts. In a 6-month online program using self-reported activity, meeting step goals and meeting minutes-based goals predicted weight loss about equally (β .24 and .20, not statistically different), but participants met their weekly step goal for only 3.5 weeks on average versus 7.1 for minutes[8]. Among 599 young adults in the SNAP weight-gain prevention trial, daily steps did not distinguish those who gained more than 1 lb over 2 years from those who did not, while moderate-to-vigorous minutes did: 49% of those under 150 minutes a week gained versus 30% of those at 250 or more[9]. Those authors concluded that increasing harder activity, rather than steps, should be the target for that age group[9].

Steps look most useful after the weight is off

Maintenance is where several data sets converge. In a primary care maintenance trial, participants who had already lost at least 5% began regaining by 24 months (a mean 4.22% increase), and fewer steps per day was among the habits most consistently associated with regain[10]. Tracker data from 3,124 All of Us participants, who were of European ancestry and walked a median of 8,326 steps a day, showed a 43% lower obesity risk at the 75th versus 25th percentile of steps[11]. That study looked at preventing obesity, and those at high genetic risk would need about 2,280 more steps a day (11,020 total) to match average-risk peers[11], so a single target may undersell what some people need.

What this means on a GLP-1

Almost none of this was measured in people on a GLP-1. The 2026 meta-analysis names the scarcity of step data during medication or surgery as a limitation[1], so the figures above come from programs without these drugs and may not transfer. What exists on medication is descriptive. Among 298 All of Us participants taking a GLP-1 between 2018 and 2022, mean steps were 5,944 a day and 57.7% did not reach 150 weekly minutes of moderate-to-vigorous activity[12]. In 581 semaglutide users tracked by Fitbit, step counts did not show sustained improvement and stayed below baseline[13]. Weight loss on the drug therefore does not appear to bring more walking along with it automatically, although these small observational samples cannot say why.

For the practical side, our page on walking while on a GLP-1 covers building a routine around low energy and nausea, and our review of under-desk treadmills looks at one way to add steps during a sitting job. Walking is also a different thing from strength work, and the studies above did not test the two against each other; our muscle-loss prevention guide covers resistance training on these drugs.

Questions to raise with your clinician or program

  • What is my real baseline this week, and is 1,000 to 1,200 more steps a day a sensible first change, given that this is the primary estimate of what programs achieved over usual care[1]?
  • Do joints, balance or heart conditions change how I should build up?
  • Once I reach a maintenance dose or goal weight, what activity level should I hold to limit regain[10]?

Frequently Asked Questions

No trial has established a required number. In randomized lifestyle programs, participants averaged about 8,450 steps a day and lost 4.39% of their weight, and in one 18-month trial those who lost at least 10% averaged 9,822. Those figures are associations from diet-based programs, and the authors of the 8,500 figure say it is not a prescription.
It has not been tested head to head. The 10,000 figure comes from sorting participants in one trial by how much they lost, so it could reflect that lighter people walk more. The 8,500 figure comes from a meta-analysis of program averages. Harder activity also seemed to matter, with about 3,500 of those steps taken in moderate-to-vigorous bouts in the top group.
It may, though the evidence is observational. Fewer steps per day was among the habits most consistently linked to regain in a primary care maintenance trial, and in a diet trial people with the largest activity increases held their loss from 6 to 24 months. The authors of a 2026 meta-analysis see steps as more tied to maintenance than to the initial loss.
One small US study of 298 adults taking a GLP-1 found a mean of 5,944 steps a day, and 57.7% did not reach 150 weekly minutes of moderate-to-vigorous activity. Another tracked 581 semaglutide users and found step counts stayed below baseline over time. Neither study tested whether a step target improves results on the drug.

References

  1. 1.Saadeddine D, Foglia M, Berri E, et al. Daily Steps During Nutritional Lifestyle Modification Programs for Obesity Management: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2026. PMID: 42074460.
  2. 2.Creasy SA, Lang W, Tate DF, et al. Pattern of Daily Steps is Associated with Weight Loss: Secondary Analysis from the Step-Up Randomized Trial. Obesity (Silver Spring). 2018. PMID: 29633583.
  3. 3.Xue Q, Li X, Ma H, et al. Changes in pedometer-measured physical activity are associated with weight loss and changes in body composition and fat distribution in response to reduced-energy diet interventions: The POUNDS Lost trial. Diabetes Obes Metab. 2022. PMID: 35112774.
  4. 4.Cai X, Qiu SH, Yin H, et al. Pedometer intervention and weight loss in overweight and obese adults with Type 2 diabetes: a meta-analysis. Diabet Med. 2016. PMID: 26926674.
  5. 5.Wong SH, Tan ZYA, Cheng LJ, Lau ST. Wearable technology-delivered lifestyle intervention amongst adults with overweight and obese: A systematic review and meta-regression. Int J Nurs Stud. 2022. PMID: 35092872.
  6. 6.Graham HE, Madigan CD, Daley AJ. Is a small change approach for weight management effective? A systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2022. PMID: 34580993.
  7. 7.Kal M, Cebi N, Kucuk Yetgin M. Comparing step count strategies: the impact of walking on cardiometabolic health in women with obesity. Cent Eur J Public Health. 2026. PMID: 42444425.
  8. 8.Stansbury ML, Krukowski RA, You W, et al. Effects of meeting steps-based and minutes-based physical activity goals on weight loss in online behavioral weight control: seemingly unrelated regression analysis. Health Psychol Behav Med. 2022. PMID: 36210867.
  9. 9.Unick JL, Lang W, Williams SE, et al. Objectively-assessed physical activity and weight change in young adults: a randomized controlled trial. Int J Behav Nutr Phys Act. 2017. PMID: 29202850.
  10. 10.Gibbs BB, Tudorascu D, Bryce CL, et al. Lifestyle Habits Associated with Weight Regain After Intentional Loss in Primary Care Patients Participating in a Randomized Trial. J Gen Intern Med. 2020. PMID: 32808209.
  11. 11.Brittain EL, Han L, Annis J, et al. Physical Activity and Incident Obesity Across the Spectrum of Genetic Risk for Obesity. JAMA Netw Open. 2024. PMID: 38536175.
  12. 12.Chae K, Jones MR, Yang A, et al. Physical Activity Patterns in Adults Taking Glucagon-Like Peptide 1 Receptor Agonists: An All of Us Cross-sectional Study. Diabetes Obes Cardiometab CARE. 2026. PMID: 42892878.
  13. 13.Butensky SD, Hamid SA, Graetz E, et al. Real-world Physical Activity and Sedentary Time Trends in Patients Undergoing Obesity Treatment: Insights From the All of Us Research Program. Obes Surg. 2026. PMID: 41912836.

Where to get GLP-1 safely: vetted online providers

Vetted telehealth providers that prescribe online. We compare pricing, form, and states served.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

8.3

CoreAge Rx

Lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

Read full review →

Pricing Compare

Get started →
7.8

Embody

Low flat-rate compounded GLP-1 pricing at every dose

Read full review →

Pricing Compare

Get started →
8.2

Gala

Compounded semaglutide or tirzepatide at one all-doses price on a yearly plan, with free shipping

Read full review →

Pricing Compare

Get started →